Abstract
Objective
The aim of this study was to investigate the characteristics of gene changes from Barrett’s esophagus (BE) to esophageal adenocarcinoma by cDNA microarray.
Methods
The cDNA retro-transcribed from equal quantity mRNA from esophageal carcinoma and BE tissues as well as control normal epithelium of esophagus which were from one patient with esophageal adenocarcinoma were labeled with Cy5 and Cy3 fluorescence as probes. The mixed probes were hybridized with two pieces gene chip respectively. It was scanned by laser scanner Scan Array 4000. The acquired images were analyzed by software GenePix Pro 3.0.
Results
A total of 214 genes were screened out which expression levels were more than 2 times in hybridization of esophageal adenocarcinoma vs normal epithelium of esophagus, whereas 90 genes in hybridization of BE vs normal epithelium. A parallel comparison among these two gene profiles showed that a total of 45 genes with 24 downregulation and 21 up-regulation which expression levels were more than 2 times between the BE and the esophageal adenocarcinoma. Among these, there were 27 genes with 18 downregulation and 9 up-regulation which implicated the tendencies progressing from BE to esophageal adenocarcinoma.
Conclusion
These genes or their products which implicate the tendencies can be chosen as indicators of carcinogenesis with high risk index for BE.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hameeteman W, Tytgat GN, Houthoff HJ, et al. Barrett’s esophagus: development of dysplasia and adenocarcinoma. Gastroenterology, 1989, 96: 1249–1256.
Menke-pluymers MB, Hop WC, Dees J, et al. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdan Esophageal Tumor Study Group. Cancer, 1993, 72: 1155–1158.
Hamilton SR. Reflux esophagitis and Barrett esophagus. Monogr Pathol, 1990, 31: 11–68.
Peng X, Yuan HY, Xie Y, et al. Experimental techniques of genetic engineering (Chinese). Changsha: Hunan Science and Technology Press, 1998: 197–199.
Mo HB, Liu Y, Cheng WQ. Study on the research of biomarkers of esophageal adenocarcinoma. Cancer Prev Treat (Chinese), 2005, 32: 519–521.
Galipeau PC, Prevo LJ, Scachez CA. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett’s) tissue. J Natl Cancer Inst, 1999, 91: 2087–2095.
Dolan K, Garde J, Walker SJ, et al. LOH at the sites of the DCC, APC, and TP53 tumor suppressor genes occurs in Barrett’s metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus. Hum Pathol, 1999, 30: 1508–1514.
Rioux-Leclercq N, Turlin B, Sutherland F, et al. Analysis of Ki67, p53 and Bcl-2 expression in the dysplasia-carcinoma sequence of Barrett’s esophagus. Oncol Rep, 1999, 6: 877–882.
Hong MK, Laskin WB, Herman BE, et al. Expansion of the Ki67 proliferation compartment correlates with degree of dysplasia in Barrett esophagus. Cancer, 1995, 75: 423–429.
Falk JW. Barrett’s esophagus. Gastroenterology, 2002, 122: 1569–1591.
Chen JW, Wu R, Yang PC, et al. Profiling expression pattern and isofferentially expressed genes by cDNA microarray system with colorimetry detection. Genomics, 1998, 51: 313–324.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, X., Zeng, H. Correlation between the gene expression profiles of adenocarcinoma of esophagus and Barrett’s esophagus. Chin. -Ger. J. Clin. Oncol. 9, 26–30 (2010). https://doi.org/10.1007/s10330-009-0184-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10330-009-0184-6